Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.

Susan Chan(The Wistar Institute), B Perussia(The Wistar Institute), Jean Gupta(The Wistar Institute), Michiko Kobayashi(The Wistar Institute), M Pospísil(The Wistar Institute), Howard A. Young(The Wistar Institute), S F Wolf(The Wistar Institute), Deborah Young(The Wistar Institute), Stephen Clark(The Wistar Institute), Giorgio Trinchieri(The Wistar Institute)
The Journal of Experimental Medicine
April 1, 1991
Cited by 986Open Access
Full Text

Abstract

We previously reported that natural killer cell stimulatory factor (NKSF), a heterodimeric lymphokine purified from the conditioned medium of human B lymphoblastoid cell lines, induces interferon gamma (IFN-gamma) production from resting peripheral blood lymphocytes (PBL) and synergizes with interleukin 2 in this activity. In this study, we show that human NKSF induces IFN-gamma production from both resting and activated human PBL and from freshly isolated murine splenocytes. Human T and NK cells produce IFN-gamma in response to NKSF, but resting PBL require the presence of nonadherent human histocompatibility leukocyte antigens DR+ (HLA-DR+) accessory cells to respond to NKSF. The mechanism(s) by which NKSF induces IFN-gamma production results in accumulation of IFN-gamma mRNA, is insensitive to cyclosporin A, and synergizes with those mediated by phytohemagglutinin, phorbol diesters, anti-CD3 antibodies, and allogeneic antigens, but not by Ca2+ ionophores. The ability of NKSF to directly induce IFN-gamma production and to synergize with other physiological IFN-gamma inducers, joined with the previously described ability to enhance lymphocyte cytotoxicity and proliferation, indicates that this lymphokine is a powerful immunopotentiating agent.


Related Papers

No related papers found

Powered by citation graph analysis